A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders

E-ISSN： 1875-6190|14|7|705-720

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.14, Iss.7, 2016-08, pp. : 705-720

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of serotonin antagonists in depressive disorders

By Thomas David R Watson Jeannette M Wood Martyn D

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 4, 2002-04 ,pp. : 457-467

Informa Healthcare

Access to resources Recommend Favorite

Small-Molecule Chemokine Receptor Antagonists: Potential Targets for Inflammatory and Allergic Disorders

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 3, Iss. 4, 2004-12 ,pp. : 363-375

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokine-Chemokine Receptor Network in Immune Cell Trafficking

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 4, 2004-12 ,pp. : 343-361

Bentham Science Publishers

Access to resources Recommend Favorite

Managing depressive and anxiety disorders with escitalopram

By Thase Michael E

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 4, 2006-03 ,pp. : 429-440

Informa Healthcare

Access to resources Recommend Favorite

The Role of Oxidative Stress in Depressive Disorders

Current Pharmaceutical Design, Vol. 18, Iss. 36, 2012-01 ,pp. : 5890-5899

Bentham Science Publishers

Access to resources Recommend Favorite